Jounce Therapeutics, Inc. Stock
Equities
JNCE
US4811161011
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Michael Hearne
DFI | Director of Finance/CFO | - | - |
Eric Laub
IRC | Investor Relations Contact | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 18 M€ | +3.26% | - |
1st Jan change | Capi. | |
---|---|---|
-2.88% | 103B | |
+0.28% | 95.71B | |
+1.05% | 22.02B | |
-17.33% | 20.9B | |
-9.19% | 17.85B | |
-42.83% | 16.21B | |
-15.95% | 15.52B | |
+4.88% | 13.86B | |
+31.65% | 12.04B |